Please Wait
Applying Filters...
menu
    • menu
    munit-sa-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    SAFC

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    This week, SpeakPharma interviews Pete Werth III, the new president of ChemWerth, a company that has been at the forefront of the generic pharmaceutical industry for over four decades. He shares his vision for ChemWerth, which includes his commitment to strengthening global manufacturing relationships, and enhancing supply chain resilience. Additionally, he highlights the key aspects of a successful drug master file (DMF). HIGHLIGHTS// Pete Werth III, the new president of ChemWerth/ vision for ChemWerth/ commitment to strengthening global manufacturing relationships/ key aspects of a successful drug master file Your father, Peter J. Werth, is recognized as one of the founders of the generic pharmaceutical industry, having built ChemWerth from the ground up over four decades ago. How do you view his legacy? As you take the helm, what key lessons or principles from his leadership do you intend to carry forward? My father, Peter J. Werth, is a true pioneer in the generic pharmaceutical industry. Over his 42‐year tenure, he not only built ChemWerth from a humble garage startup into a global leader in generic API development but also established standards that many in our industry now take for granted. Under his leadership, we filed our very first DMF in 1987 and have since achieved more than 500 DMF filings. With an average review cycle of just 0.79, we have been far outperforming the industry average of 2.5 cycles. His focus on quality, regulatory excellence, and a relentless commitment to customers’ success set the foundation for our reputation as a trusted supplier of over 500 APIs sourced from more than 30 cGMP-certified facilities worldwide. Equally inspiring is his dedication to nurture long-term, mutually beneficial relationships with manufacturing partners across the US, Europe, India, and China, as well as his passion for giving back to the community through philanthropic initiatives. As I take the helm, I intend to build on his guiding principles — sustaining our high standards of quality and compliance while pursuing innovation in regulatory strategy, diversifying our supply chain, and embracing new technologies and approaches to remain competitive in an evolving market. I will also strive to continue his legacy of mentorship, ensuring that our company culture remains rooted in integrity and diligence, with an unyielding focus on making safe, affordable medicines available worldwide. HIGHLIGHTS// trusted supplier of over 500 APIs/ 30 cGMP-certified facilities worldwide/ embracing new technologies and approaches to remain competitive What are your top priorities as the new president of ChemWerth? How do you plan to strengthen and expand relationships with manufacturers worldwide? My immediate priorities as the new president are twofold: to enhance the value we deliver to our customers and, to deepen our relationships with our manufacturing partners worldwide. We will further diversify our supply chain and broaden our product portfolio. Our expansion plans include upgrading equipment, and hiring additional highly skilled scientists, engineers, and GMP auditors. We will also leverage our proprietary product selection and regulatory submission processes. These processes help us get the regulatory filing right the first time, and allows us to be approved 44 percent faster than the industry average. This helps our customers gain a competitive edge in the market. In essence, by strengthening operational excellence and expanding our global network, we intend to continue the company’s long-standing commitment to customer success and process innovation. We plan to reinforce our long-standing relationships with our manufacturers — especially those in strategic markets like China and India — by helping our partners meet the highest standards of regulatory compliance and current good manufacturing practice (cGMP) quality. This balanced approach of strengthening existing partnerships while pioneering new ones is key to maintaining and growing our competitive edge. HIGHLIGHTS// diversify our supply chain and broaden our product portfolio/ commitment to customer success and process innovation/ filings approved 44 percent faster than the industry average When ChemWerth last spoke to PharmaCompass, there was a mention of investing millions of dollars in expanding manufacturing partnerships in China and India. Can you elaborate on the success of these partnerships, and how have they contributed to ChemWerth’s overall growth? Our strategic, multimillion-dollar investments in manufacturing partnerships are a cornerstone of our growth strategy. Over the past few years, these joint ventures have proven their worth by diversifying our supply base and mitigating the risk of global supply chain disruptions — a lesson that became all too clear during the Covid-19 pandemic. These investments are already paying dividends. They help us support manufacturers producing steroids, hormones, veterinary products, and large-volume APIs, while also accelerating the development of small-molecule inhibitors and new generic APIs. We have ensured that our partners are equipped with the latest equipment and trained personnel to meet cGMP standards. By partnering with facilities in these markets, we now have access to state-of-the-art production capabilities that enable us to produce a wider range of APIs at competitive costs. The success of these partnerships is evident in our ability to consistently file DMFs rapidly — often on the first cycle — and deliver affordable, high-quality medicines to patients worldwide. This supports our clients’ growth trajectory and has helped us expand into new markets. This strategy has reinforced our global footprint — supporting our presence in 38 countries with over 100 products — and positioned us well to capitalize on a global generic drug market projected to grow at a compounded annual growth rate of 5.4 percent from 2022 to 2030, to reach a size of US$ 671 billion by 2030. HIGHLIGHTS// strategic multimillion-dollar investments/ support manufacturers producing steroid, hormone, veterinary products/ development of small-molecule inhibitors and new generic APIs/ ensured partners are equipped with the latest equipment and trained personnel ChemWerth has an impressive track record, and an over 40-year relationship with the US Food and Drug Administration (FDA). What are the key aspects of a successful DMF? Are there specific challenges manufacturers face in preparing DMFs, and how does ChemWerth help them overcome these hurdles? ChemWerth’s record of filing over 500 DMFs in 38 countries reflects our commitment to excellence in regulatory compliance and quality management. A successful DMF is built on comprehensive documentation that rigorously follows cGMP guidelines, robust analytical validation, and detailed tracking of every step. Every DMF we file meticulously details the entire manufacturing process — from raw material acquisition to final batch production. This comprehensive approach ensures that our submissions meet the rigorous quality, safety, and efficacy standards expected by the FDA. Our team stays continuously updated on the evolving guidelines and protocols, which allows us to file DMFs that align with current FDA practices. We recognize that many manufacturers face challenges such as complex regulatory requirements, lengthy review cycles, and the need for precise coordination between various production stages. ChemWerth helps them overcome these hurdles by offering end-to-end regulatory support, detailed internal audits, and continuous training on cGMP and FDA requirements. Our efficiency is a critical competitive advantage. By receiving approvals 44 percent faster than the industry average, we help our customers get their products to market faster, resulting in larger market share and increased profits. HIGHLIGHTS// over 500 DMFs in 38 countries/ robust analytical validation/ end-to-end regulatory support What is your vision for ChemWerth over the next few years? How do you plan to navigate the challenges and opportunities in the generic pharmaceutical industry? I plan to continue to add value for our customers, and look for innovative ways to compete in today’s generic pharmaceutical landscape. At ChemWerth, our vision for the future is rooted in both our proud legacy and our relentless drive for innovation. We will further diversify our supply chain and expand our product portfolio. We have begun leveraging our expertise to supply APIs for biosimilars and new drug applications (NDAs), while maintaining our reputation for rapid regulatory approvals. With unwavering determination, we uphold our “First to Quality. Fast to Market.” approach — delivering high-quality APIs to customers worldwide while leveraging our expertise to give them a competitive edge in their markets. HIGHLIGHTS// supply APIs for biosimilars and NDAs/ give customers a competitive edge in their markets 

    Impressions: 885

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage

    Radio Compass
    12 Mar 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    CDMO Activity Tracker: Axplora enhances ADC capacities, Quotient beefs up HPAPI capabilities; Evonik, EUROAPI forge deals

    CDMO Activity Tracker: Axplora enhances ADC capacities, Quotient beefs up HPAPI capabilities; Evonik, EUROAPI forge deals

    The contract development and manufacturing organization (CDMO) sector witnessed significant activity in the first quarter (Q1) of 2025, characterized by strategic investments, facility expansions, and collaborative partnerships.The quarter saw some significant deals. WuXi Biologics agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to Merck for € 500 million (US$  521 million). Quadria Capital announced the acquisition of a 10 percent stake in Aragen for US$ 100 million. This investment will help Aragen accelerate its research and development efforts.Some CDMOs, like India-based Syngene International and Belgium-based Ardena expanded their presence in the US market. Syngene completed the acquisition of its first US biologics facility that it had purchased from Emergent Manufacturing Operations Baltimore for US$ 36.5 million. And, leading nanomedicine developer Ardena purchased a drug manufacturing unit in New Jersey from Catalent.  View CDMO Activity Tracker for Q1 2025 (Free Excel Available) Axplora expands its ADC capacities; Quotient Sciences wraps up HPAPI unit upgradeThe antibody-drug conjugate (ADC) market saw considerable investments by CDMOs. Axplora expanded its commercial payload production capabilities at its Le Mans site in France, reinforcing its position as a leading player in ADC manufacturing. This expansion is part of the France 2030 program and builds on Axplora’s track record of supplying 40 percent of the world’s marketed ADCs and 50 percent of ADCs approved by the US Food and Drug Administration (FDA).Samsung Biologics said it will support a series of LigaChem Biosciences’ ADC programs at its new dedicated ADC facility. Similarly, Cerbios-Pharma announced significant enhancements to its ADC production capabilities. Cerbios also announced the expansion of its high potency active pharmaceutical ingredients (HPAPIs) production capabilities. On March 31, Cerbios-Pharma got acquired by Healthcare Advanced Synthesis, a leading developer of APIs, HPAPIs and anticancer compounds. Both these global players are based in Switzerland. Overall, HPAPIs saw significant investments. Quotient Sciences made headlines with the successful completion of a US$ 1.4 million project designed to improve high potency handling capabilities at its Philadelphia (US) facility. The initiative focused on upgrading infrastructure and implementing advanced safety protocols to manage HPAPIs more effectively.Polfa Tarchomin achieved significant milestones in enhancing its pharmaceutical manufacturing capabilities. The company successfully completed the site acceptance test (SAT) for its vial filling and packaging line at the Center for Development and Production of Highly Potent Drugs, ensuring full functionality and compliance with good manufacturing practice (GMP) standards.Additionally, Polfa Tarchomin is installing a high-tech, high-containment robotic ONCO LINE designed for aseptic production of highly potent pharmaceutical products, including lyophilisates and liquid formulations in vials and pre-filled syringes. Developed in collaboration with leading global suppliers, this line supports multiple packaging formats and comes with advanced systems. With an annual production capacity of up to 6 million units, this line will set a new benchmark in pharmaceutical manufacturing.In a significant development for analytical testing, SK Pharmteco launched an enhanced laboratory specifically designed for HPAPIs. The new facility is in California (US).  View CDMO Activity Tracker for Q1 2025 (Free Excel Available) Evonik expands RNA portfolio; Catalent to support Galapagos’ CAR-T therapy trialsThe success of mRNA vaccines and the growing interest in RNA therapeutics is luring CDMOs to rapidly expand their capabilities in this emerging area. Evonik, in collaboration with ST Pharm, announced plans to expand its portfolio of RNA and nucleic acid therapeutic services during Q1. The partnership enables Evonik to provide customized nucleic acids from ST Pharm alongside its portfolio of lipid and lipid nanoparticle (LNP) drug product development services.ReciBioPharm secured a grant from the Bill & Melinda Gates Foundation to advance RNA manufacturing technologies that meet FDA standards with a focus on improving access to RNA therapeutics in low- and middle-income countries.The cell and gene therapy sector also witnessed remarkable activity in Q1 2025. Catalent announced it will support Galapagos’ decentralized CAR T therapy trials for GLPG5101 for relapsed/refractory non-Hodgkin lymphoma indications.Similarly, AGC Biologics announced it will manufacture and supply lentiviral vectors for Adaptimmune’s solid tumor cell therapy initiatives. And, Genenta and AGC Biologics strengthened their cell therapy manufacturing pact through a collaboration agreement. This grants Genenta access to the exclusive GMP suite at the AGC Biologics Cell and Gene Center of Excellence in Milan, dedicated to manufacturing cell therapy products.  View CDMO Activity Tracker for Q1 2025 (Free Excel Available) EUROAPI, StrainChem join hands to develop peptides; Fermion expands flow chemistry capabilitiesEven traditional therapeutics like peptides and small molecules saw considerable investments by CDMOs. For instance, EUROAPI and StrainChem announced a collaborative venture to develop liquid phase peptides. The partnership aims to harness advanced synthesis techniques and innovative technologies for more efficient peptide manufacturing. Through this collaboration, EUROAPI and StrainChem will offer their customers a one-stop shop solution for peptides. In one of the most ambitious expansions announced this quarter, CordenPharma unveiled plans to invest over € 1 billion (US$ 1.10 billion) over the next three years in building and expanding small, medium, and large peptide manufacturing facilities across Europe and the US. That includes a new greenfield facility for peptide manufacturing in the Basel region of Switzerland, valued at over € 500 million (US$ 553 million).In obesity treatments, Viking Therapeutics agreed to pay US$ 150 million to CordenPharma for the production of its dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) agonist VK2735.In a show of confidence, Indian CDMO Neuland Labs’ board approved a ₹ 3.42 billion (approximately US$ 42 million) capital expenditure plan. The approved capex is earmarked for enhancing the company’s peptide synthesizer reactor capacity and building additional capacity to meet growing demand.In the small molecule space, Fermion announced a strategic investment to expand its flow chemistry capabilities, aiming to enhance processes and sustainability by integrating continuous flow techniques into manufacturing. This technology offers advantages in scalability, process control, and safety, positioning Fermion at the forefront of pharmaceutical innovation.Recipharm announced a major expansion of its aseptic filling capabilities, encompassing process development, pilot-scale production, and clinical supply operations. Similarly, Curia announced significant expansions to its global network of sterile fill-finish sites, aiming to enhance production capacity, streamline supply chains, and improve overall quality in sterile pharmaceutical manufacturing.  View CDMO Activity Tracker for Q1 2025 (Free Excel Available) Our viewDuring Q1 2025, the CDMO sector continued to evolve towards higher-value and more complex services. This only underscores the crucial role CDMOs are playing in supporting growth and innovation in the pharmaceutical industry.With the Trump administration in the US triggering a global tariff war, drugmakers have no option but to reshape their supply chains. And this means more business for CDMOs that manufacture drugs in the US. In the coming quarter, we expect strong dealmaking and increased focus on innovation in the CDMO sector. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 1713

    https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-axplora-enhances-adc-capacities-quotient-beefs-up-hpapi-capabilities-evonik-euroapi-forge-deals

    #PharmaFlow by PHARMACOMPASS
    10 Apr 2025
    Share Share

    NEWS #PharmaBuzz

    [Sponsored by another company]read-more
    read-more
    Merck unveils EU plant cuts and consolidation plan citing Sigma's US strategy
    Merck unveils EU plant cuts and consolidation plan citing Sigma's US strategy

    14 Jul 2017

    // G. MacDonald IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Processing/German-Merck-announces-EU-plant-cuts-and-consolidation-plan

    G. MacDonald IN PHARMATECHNOLOGIST
    14 Jul 2017
    Share Share
    EC says Merck and Sigma-Aldrich broke M&A procedures and could face $170m fine
    EC says Merck and Sigma-Aldrich broke M&A procedures and could face $170m fine

    07 Jul 2017

    // G. MacDonald IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Processing/EC-says-Merck-and-Sigma-Aldrich-broke-M-A-procedures

    G. MacDonald IN PHARMATECHNOLOGIST
    07 Jul 2017
    Share Share
    Improving solubility: MilliporeSigma opens dedicated meglumine site
    Improving solubility: MilliporeSigma opens dedicated meglumine site

    19 Jan 2017

    // Dan Stanton IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Ingredients/Improving-solubility-MilliporeSigma-opens-dedicated-meglumine-site

    Dan Stanton IN PHARMATECHNOLOGIST
    19 Jan 2017
    Share Share
    MilliporeSigma Expands Distribution Agreement with Roche in Canada
    MilliporeSigma Expands Distribution Agreement with Roche in Canada

    01 Dec 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/milliporesigma-expands-distribution-agreement-with-roche-in-canada-300367603.html

    PR NEWSWIRE
    01 Dec 2016
    Share Share
    Honeywell Launces New Research Chemicals Business
    Honeywell Launces New Research Chemicals Business

    29 Nov 2016

    // DRUG DEVELOPMENT

    http://www.drug-dev.com/Main/Current-News/Honeywell-Launces-New-Research-Chemicals-Business-1770.aspx

    DRUG DEVELOPMENT
    29 Nov 2016
    Share Share
    Merck's pharma unit faces tougher 2017 as fertility boost recedes
    Merck's pharma unit faces tougher 2017 as fertility boost recedes

    17 Nov 2016

    // Phil Taylor PMLIVE

    http://www.pmlive.com/pharma_news/mercks_pharma_unit_faces_tougher_2017_as_fertility_boost_recedes_1176998

    Phil Taylor PMLIVE
    17 Nov 2016
    Share Share
    Contact Safc and get a quotation

    Safc is a supplier offers 204 products (APIs, Excipients or Intermediates).

    Find a price of Benzyl Alcohol API bulk with DMF, CEP offered by Safc

    Find a price of Clomipramine Hydrochloride bulk with DMF, CEP offered by Safc

    Find a price of Dactinomycin bulk with DMF, JDMF offered by Safc

    Find a price of Doxylamine Succinate bulk with DMF, CEP offered by Safc

    Find a price of L-Glutamine bulk with DMF, JDMF offered by Safc

    Find a price of Sodium Benzoate bulk with DMF, CEP offered by Safc

    Find a price of L-Glutamine bulk with JDMF offered by Safc

    Find a price of Sodium Bicarbonate bulk with JDMF offered by Safc

    Find a price of Aprotinin bulk with CEP offered by Safc

    Find a price of Bovine Serum bulk with CEP offered by Safc

    Find a price of Brompheniramine Maleate bulk with DMF offered by Safc

    Find a price of Catalase bulk with CEP offered by Safc

    Find a price of Cholic Acid bulk with DMF offered by Safc

    Find a price of Chymotrypsin bulk with CEP offered by Safc

    Find a price of Dodecyl Maltoside bulk with DMF offered by Safc

    Find a price of DPPC bulk with DMF offered by Safc

    Find a price of Ethanol bulk with DMF offered by Safc

    Find a price of Glucarpidase bulk with CEP offered by Safc

    Find a price of Glucose bulk with JDMF offered by Safc

    Find a price of Glycine bulk with DMF offered by Safc

    Find a price of Hyaluronidase bulk offered by Safc

    Find a price of L-Carnosine bulk with CEP offered by Safc

    Find a price of L-Glutamine bulk with DMF offered by Safc

    Find a price of L-Tyrosine API bulk with JDMF offered by Safc

    Find a price of Levothyroxine Sodium bulk with DMF offered by Safc

    Find a price of Lysine Hydrochloride bulk with DMF offered by Safc

    Find a price of Maytansinoid DM1 bulk with DMF offered by Safc

    Find a price of Mebrofenin bulk with DMF offered by Safc

    Find a price of Nortriptyline bulk with DMF offered by Safc

    Find a price of Palmitic Acid Chloride bulk with DMF offered by Safc

    Find a price of Sodium Metaarsenite bulk with DMF offered by Safc

    Find a price of Sulfo-Smcc bulk with DMF offered by Safc

    Find a price of Tripalmitin bulk with DMF offered by Safc

    Find a price of Trypan Blue bulk with DMF offered by Safc

    Find a price of Urea API bulk with DMF offered by Safc

    Find a price of Vitamin D bulk with DMF offered by Safc

    Find a price of CELL CULTURE MEDIUM CR40118 bulk with DMF offered by Safc

    Find a price of EX-CELL(TM) 325 PF CHO, SERUM-FREE MEDIUM, PROTEIN FREE bulk with DMF offered by Safc

    Find a price of QBSF60 MEDIUM PRODUCT NO. 62520 bulk with DMF offered by Safc

    Find a price of EX-CELL CD HEK293 VIRAL VECTOR MEDIUM bulk with DMF offered by Safc

    Find a price of CELL CULTURE MEDIUM CR60275 bulk with DMF offered by Safc

    Find a price of CELL CULTURE MEDIUM CR60258 CHOKO PRODUCTION MEDIUM POWDER bulk with DMF offered by Safc

    Find a price of CELL CULTURE MEDIUM CR60219 bulk with DMF offered by Safc

    Find a price of CELL CULTURE MEDIUM CR60234 bulk with DMF offered by Safc

    Find a price of EX-CELL PF CHO MEDIUM (MODIFIED) DEFICIENT bulk with DMF offered by Safc

    Find a price of CELL CULTURE MEDIUM CR60259, CHOKO STOCK CULTURE MEDIUM POWDER bulk with DMF offered by Safc

    Find a price of CELL CULTURE MEDIUM CR60256 CHOKO FMA POWDER bulk with DMF offered by Safc

    Find a price of CELL CULTURE MEDIUM CR60274 bulk with DMF offered by Safc

    Find a price of CELL CULTURE MEDIUM CR60229 bulk with DMF offered by Safc

    Find a price of MAYTANSINOL-N-METHYL-L-ALANYL ESTER bulk with DMF offered by Safc

    Find a price of EX-CELL PF CHO PART A (MODIFIED) bulk with DMF offered by Safc

    Find a price of CELL CULTURE MEDIUM 14366C bulk with DMF offered by Safc

    Find a price of CELL CULTURE MEDIUM CR60257, CHOKO FMB POWDER bulk with DMF offered by Safc

    Find a price of CELL CULTURE MEDIUM CR60273 bulk with DMF offered by Safc

    Find a price of Medium/medium additive ・R36 Low B12 bulk with JDMF offered by Safc

    Find a price of Medium / medium additive · StemlineⅡ Hematopoietic Stem C ell Expansion Medium bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additive / PER2 bulk with JDMF offered by Safc

    Find a price of Media/Media Additives GS2-N Low B12 No Hydrocort bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additives-SuppAA-1 bulk with JDMF offered by Safc

    Find a price of Medium/Medium additives・40X Insect Cell Feed bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additives-EX-CELL Advanced CHO Feed 1 bulk with JDMF offered by Safc

    Find a price of Medium/Medium additives・EX-CELL(R) Basal Medium bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additives-EX-CELL Advanced CHO Feed 1 (without glucose) bulk with JDMF offered by Safc

    Find a price of Medium/Medium additives・EX-CELL(R) Feed Medium bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additive ・ CHOKO Production Medium Powerer bulk with JDMF offered by Safc

    Find a price of Medium/Medium additives/GM BI 215 Medium Powder bulk with JDMF offered by Safc

    Find a price of Medium/Medium additives/GM BI 203 Medium Powder bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additives ・ CHOKO Stock Culture Medium Powerer bulk with JDMF offered by Safc

    Find a price of Culture medium/Culture additives: EX-CELL® Advanced CHO Fed-batch Medium bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additives ・ CHOKO FMA Powerer bulk with JDMF offered by Safc

    Find a price of Medium / medium additive · C8862: EX-CELL CHO DHFR\n- Medium bulk with JDMF offered by Safc

    Find a price of Medium / medium additive · Fatty Acid Supplement bulk with JDMF offered by Safc

    Find a price of Media/Medium Additives・EX-CELL EBx PRO-I Serum-Free Media bulk with JDMF offered by Safc

    Find a price of Medium/medium additive R7A-1 bulk with JDMF offered by Safc

    Find a price of Medium / medium additive · CHO Feed Bioreactor Supplement bulk with JDMF offered by Safc

    Find a price of Media/Media Additives ・Trace Element E 1000X Solution bulk with JDMF offered by Safc

    Find a price of Medium / medium additive · EX-CELL 325 PF CHO Serum-Fr ee Medium for CHO Cells bulk with JDMF offered by Safc

    Find a price of Medium/medium additive EX-CELL (R) 293 Serum-Free Medium for HEK 293 Cells bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additives-EX-CELL (TM) CD Hydrolysate Fusion Animal Coordinate Free, Chemically Defined bulk with JDMF offered by Safc

    Find a price of Medium/medium additive ・F48 Low B12 no HC bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additive ・ IMF9-2X bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additive / IMF8 bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additives-EX-CELL ACF CHO Medium bulk with JDMF offered by Safc

    Find a price of Medium/Medium additives/GM BI 221 Feed Powder bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additives ・ CHOKO FMB Powerer bulk with JDMF offered by Safc

    Find a price of Medium / medium additive · Sigma EX-CELL 302 Serum-Fr ee Medium for CHO Cells bulk with JDMF offered by Safc

    Find a price of Medium / medium additive · EX-CELL EBx PRO-Ⅰ Serum-Fre e Medium for Embryonic Stem Cells bulk with JDMF offered by Safc

    Find a price of Medium/Medium Additives・EX-CELL EBx PRO-I Serum-Free Medium for Embryonic Stem Cells bulk with JDMF offered by Safc

    Find a price of Culture medium/Culture additives・EX-CELL EBx GRO-I Serum-Free Media bulk with JDMF offered by Safc

    Find a price of Medium / medium additive · EX-CELL EBx PRO-Ⅰ Serum-Fre e Media bulk with JDMF offered by Safc

    Find a price of Medium/medium additive R17 bulk with JDMF offered by Safc

    Find a price of Medium / media supplements · EX-CELL (TM) 325 PF CHO Protei n-Free Medium (Modified) bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additive ・ TE1 bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additive / IMB9 bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additive / IMB8 bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additives-EX-CELL Advanced (TM) Modified bulk with JDMF offered by Safc

    Find a price of Medium / Medium Additives ・ CHO Kit 2 Iron Chelator Solution bulk with JDMF offered by Safc

    Find a price of Medium / medium additive · Sigma EX-CELL PF CHO Mediu m (Modified) bulk with JDMF offered by Safc

    Find a price of Medium / medium additive · Ex-CELL EBx GRO-Ⅰ Serum-Fre e Medium for Embryonic Stem Cells bulk with JDMF offered by Safc

    Find a price of Medium/Medium Additives・Ex-CELL EBx GRO-I Serum-Free Medium for Embryonic Stem Cells bulk with JDMF offered by Safc

    Find a price of Medium/medium additive ・R34B Medium bulk with JDMF offered by Safc

    Find a price of Deoxyribonuclease I, Desoxyribonuclease I Crude Lyophilized Powder, Product Number D0876/DN25 and Desoxyribonuclease I Type II, Product Number D4527 bulk with CEP offered by Safc

    Find a price of Medium/medium additive ・Trace Element B Solution B (1000X) bulk with JDMF offered by Safc

    Find a price of Medium / medium additive · EX-CELL EBx GRO-Ⅰ Serum-Fre e Media bulk with JDMF offered by Safc

    Find a price of 3-5-Diiodothyropropionic Acid bulk offered by Safc

    Find a price of 3-Amino-3-3-Chlorophenyl-Propanoic Acid bulk offered by Safc

    Find a price of Ammonium Tetrathiomolybdate bulk offered by Safc

    Find a price of Armodafinil bulk offered by Safc

    Find a price of Bovine Insulin bulk offered by Safc

    Find a price of Bovine Serum bulk offered by Safc

    Find a price of Calcipotriol bulk offered by Safc

    Find a price of Calcitriol bulk offered by Safc

    Find a price of Camptothecine bulk offered by Safc

    Find a price of Carbamazepine bulk offered by Safc

    Find a price of Cetyl Alcohol API bulk offered by Safc

    Find a price of Cholesterol-3,4-13C2 bulk offered by Safc

    Find a price of Copper bulk offered by Safc

    Find a price of Cortisol-9,11,12,12-D4 bulk offered by Safc

    Find a price of Dextrans bulk offered by Safc

    Find a price of Fenbendazole bulk offered by Safc

    Find a price of Galactomannan bulk offered by Safc

    Find a price of Gentisic Acid bulk offered by Safc

    Find a price of GUANIDINE HYDROCHLORIDE API bulk offered by Safc

    Find a price of Halobetasol bulk offered by Safc

    Find a price of Halofuginone Lactate bulk offered by Safc

    Find a price of Hexadimethrine Bromide bulk offered by Safc

    Find a price of Homotaurine bulk offered by Safc

    Find a price of Hydroxydopamine Hydrobromide bulk offered by Safc

    Find a price of Iron bulk offered by Safc

    Find a price of Isobutylmethylxanthine bulk offered by Safc

    Find a price of Isobutyramide bulk offered by Safc

    Find a price of Isosulfan Blue bulk offered by Safc

    Find a price of L-Carnosine bulk offered by Safc

    Find a price of L-Glutamine bulk offered by Safc

    Find a price of Mafodotin [Usan] bulk offered by Safc

    Find a price of Mebrofenin bulk offered by Safc

    Find a price of Mechlorethamine bulk offered by Safc

    Find a price of Methacetin-13C bulk offered by Safc

    Find a price of Methyl Tert-Butyl Ether bulk offered by Safc

    Find a price of Methylformamide bulk offered by Safc

    Find a price of Pefcalcitol bulk offered by Safc

    Find a price of Penicillamine bulk offered by Safc

    Find a price of Pentamidine Isethionate bulk offered by Safc

    Find a price of Percorten bulk offered by Safc

    Find a price of Polygalacturonic Acid bulk offered by Safc

    Find a price of Promethazine Hydrochloride bulk offered by Safc

    Find a price of Putrescine Hydrochloride bulk offered by Safc

    Find a price of Rhodamine 123 bulk offered by Safc

    Find a price of Sodium Bicarbonate bulk offered by Safc

    Find a price of Sodium Butyrate bulk offered by Safc

    Find a price of Sodium Metaarsenite bulk offered by Safc

    Find a price of Sodium Octanoate-1-13C bulk offered by Safc

    Find a price of Squalene API bulk offered by Safc

    Find a price of Thrombin bulk offered by Safc

    Find a price of Trypan Blue bulk offered by Safc

    Find a price of Vitamin D3 bulk offered by Safc

    Find a price of EX-CELL 302 MEDIUM (MODIFIED) CAT. #62630 bulk offered by Safc

    Find a price of EX-CELL 325 PF CHO PROTEIN FREE MEDIUM bulk offered by Safc

    Find a price of 93% DME (HG)/5% NCTC (CAT. NO. 52-589) bulk offered by Safc

    Find a price of EX-CELL 525 FOR PER C6 CELLS, DEFINED SERUM FREE MEDIUM bulk offered by Safc

    Find a price of EX-CELL PF CHO MEDIUM (MODIFIED) CATALOG NO. 67480 bulk offered by Safc

    Find a price of PEG TELOMER B bulk offered by Safc

    Find a price of 9-AMINO-1,2,3,4,-TETRAHYDROCRIDINE HCL. (THA) bulk offered by Safc

    Find a price of 67210 bulk offered by Safc

    Find a price of SGD-1006 (SG6) bulk offered by Safc

    Find a price of PF-11 bulk offered by Safc

    Find a price of STEMLINE(TM) DENDRITIC CELL MATURATION MEDIUM bulk offered by Safc

    Find a price of CHO MEDIUM MODIFICATION 21 bulk offered by Safc

    Find a price of EX-CELL (TM) 293 MEDIUM bulk offered by Safc

    Find a price of EX-CELL(TM) 302, MEDIUM, SERUM-FREE MEDIUM bulk offered by Safc

    Find a price of EX-CELL(TM) 302, CHO, SERUM-FREE MEDIUM bulk offered by Safc

    Find a price of EX-CELL PF CHO MEDUIM (MODIFIED), CATALOG NO. 62625 bulk offered by Safc

    Find a price of EX-CELL (TM) VPRO bulk offered by Safc

    Find a price of ROSE BENGAL, DISODIUM SALT, SIGMA-ALDRICH CHEMICAL CO. PRODUCT NUMBER W184-3 bulk offered by Safc

    Find a price of DMS-12 (100X) CONCENTRATE bulk offered by Safc

    Find a price of EX-CELL PF CHO MEDIUM (MODIFIED) DEFINED SERUM-FREE MEDIUM bulk offered by Safc

    Find a price of Q1196-9 bulk offered by Safc

    Find a price of EX-CELL PF CHO bulk offered by Safc

    Find a price of EX-CELL 302 MEDIUM (GS MODIFIED), CATALOG NO. 62639 bulk offered by Safc

    Find a price of PHOSPHATE BUFFERED SALINE (PRODUCT 62137) bulk offered by Safc

    Find a price of EX-CELLr ANTIFOAM GAMMA IRRADIATED BY SER-TAINr PROCESS bulk offered by Safc

    Find a price of EX-CELL 400 bulk offered by Safc

    Find a price of EX-CELL 325 PF CHO (MODIFIED) PRODUCT NO. 63131 bulk offered by Safc

    Find a price of HEMOCYANIN FROM KEYHOLE LIMPET bulk offered by Safc

    Find a price of STEMLINE NEURAL STEM CELL EXPANSION MEDIUM bulk offered by Safc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN WISCONSIN. bulk offered by Safc

    Find a price of EX-CELL(TM) 302, CHO, SERUM-FREE MEDIUM(MODIFIED) bulk offered by Safc

    Find a price of CHO ANIMAL-FREE MEDIUM MODIFICATION 21 bulk offered by Safc

    Find a price of 2-METHOXYESTRA-3,17 B-DIOL bulk offered by Safc

    Find a price of EX-CELL(TM) 325 PF CHO PROTEIN-FREE MEDIUM (MODIFIED) bulk offered by Safc

    Find a price of BIOTAIN-MPS TM CONCENTRATE (100X) bulk offered by Safc

    Find a price of EX-CELL PF CHO MEDIUM(MODIFIED) bulk offered by Safc

    Find a price of STEMMAX(TM), PRODUCT NO. 62647 bulk offered by Safc

    Find a price of 1(2PHENYLETHYL)4(N(2PYRAZYL)2(FUROYLAMIDO)PIPERIDINE HCl bulk offered by Safc

    Find a price of EX-CELL 301 COMPLETE MEDIUM (MODIFIED) bulk offered by Safc

    Find a price of 62180 bulk offered by Safc

    Find a price of EX-CELL CD HYDROLYSATE FUSION, ANIMAL COMPONENT FREE, CHEMICALLY-DEFINED LIQUID MEDIA, (PRODUCT NO. 14700C), DRY POWDER MEDIA (PRODUCT NO. 24700C) bulk offered by Safc

    Find a price of EX-CELL 301 bulk offered by Safc

    Find a price of STEMLINE™ MESENCHYMAL STEM CELL EXPANSION MEDIUM bulk offered by Safc

    Find a price of SERUM-FREE MEDIA SUPPLEMENT PART A (100 X) bulk offered by Safc

    Find a price of ISCOVE'S MODIFIED DULBECCO'S MEDIUM (IMDM) bulk offered by Safc

    Find a price of STEMLINE(TM) II HEMATOPOIETIC STEM CELL EXPANSION MEDIUM bulk offered by Safc

    Find a price of EX-CELL 610 HSF HYBRIDOMA, SERUM-FREE MEDUIM. CATALOG NO. 14610 bulk offered by Safc

    Find a price of CHO MEDIUM-ANIMAL COMPONENT-FREE bulk offered by Safc